Medicure (MCUJF) Short Interest Ratio & Short Volume $0.60 +0.00 (+0.25%) As of 01/6/2025 10:47 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Medicure Short Interest DataMedicure (MCUJF) has a short interest of 900 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 6,520 shares to cover all short positions.Current Short Interest900 sharesPrevious Short Interest900 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$630.00Short Interest Ratio0.3 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares10,436,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume440 sharesAverage Trading Volume6,520 sharesToday's Volume Vs. Average7% Short Selling Medicure? Sign up to receive the latest short interest report for Medicure and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMCUJF Short Interest Over TimeMCUJF Days to Cover Over TimeMCUJF Percentage of Float Shorted Over Time Ad Behind the MarketsElon Musk’s FINAL MoveI call it "Elon's Final Move" because his new AI venture will dominate Tesla...Get all the details here >>> Medicure Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/2024900 shares $630.00 No ChangeN/A0.3 $0.70 11/30/2024900 shares $630.00 -18.2%N/A1 $0.70 11/15/20241,100 shares $637.12 No ChangeN/A2.8 $0.58 10/31/20241,100 shares $693.00 No ChangeN/A1.4 $0.63 8/15/2024100 shares $71.71 -80.0%N/A0 $0.72 7/31/2024500 shares $370.00 No ChangeN/A0.2 $0.74 Get the Latest News and Ratings for MCUJF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024500 shares $450.00 -58.3%N/A1.3 $0.90 6/30/20241,200 shares $1,033.20 No ChangeN/A1.7 $0.86 6/15/20241,200 shares $925.80 +200.0%N/A0.2 $0.77 5/31/2024400 shares $300.00 +33.3%N/A0.1 $0.75 5/15/2024300 shares $237.00 No ChangeN/A0.2 $0.79 4/15/20246,400 shares $5,083.52 -3.0%N/A2.7 $0.79 3/31/20246,600 shares $5,610.00 +1.5%N/A5.1 $0.85 3/15/20246,500 shares $5,130.45 -38.1%N/A4.6 $0.79 2/29/202410,500 shares $9,240.00 +61.5%N/A52.5 $0.88 2/15/20246,500 shares $6,162.00 -15.6%N/A1.9 $0.95 1/15/20247,900 shares $6,125.66 -1.3%N/A0 $0.78 12/31/20238,000 shares $6,203.20 -9.1%N/A32.1 $0.78 12/15/20238,800 shares $8,328.32 No ChangeN/A4.9 $0.95 11/30/20238,800 shares $10,296.00 No ChangeN/A2 $1.17 11/15/20238,800 shares $9,152.00 -10.2%N/A1.6 $1.04 10/31/20239,800 shares $10,682.00 +226.7%N/A2.6 $1.09 10/15/20233,000 shares $3,720.00 +7.1%N/A30 $1.24 9/30/20232,800 shares $3,080.00 +86.7%N/A0.5 $1.10 9/15/20231,500 shares $1,635.00 +275.0%N/A0.2 $1.09 8/31/2023400 shares $381.00 +300.0%N/A0.1 $0.95 8/15/2023100 shares $103.00 No ChangeN/A0 $1.03 7/31/2023100 shares $106.00 -97.9%N/A0 $1.06 7/15/20234,800 shares $4,105.44 No ChangeN/A1.3 $0.86 6/30/20234,800 shares $4,800.00 +9.1%N/A0.5 $1.00 6/15/20234,400 shares $3,938.00 +340.0%N/A0.4 $0.90 5/31/20231,000 shares $925.70 +900.0%N/A1 $0.93 5/15/2023100 shares $80.90 No ChangeN/A0 $0.81 4/30/2023100 shares $95.00 -97.1%N/A0 $0.95 4/15/20233,500 shares $3,255.00 +133.3%N/A0.4 $0.93 3/31/20231,500 shares $1,230.00 +1,400.0%N/A1.5 $0.82 3/15/2023100 shares $74.10 -66.7%N/A0 $0.74 2/28/2023300 shares $258.00 -40.0%N/A0.1 $0.86 2/15/2023500 shares $439.00 -58.3%N/A0.1 $0.88 1/31/20231,200 shares $1,148.28 +1,100.0%N/A0.4 $0.96Vladimir Lenin was right… (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. 1/15/2023100 shares $85.55 No ChangeN/A0 $0.86 12/30/2022100 shares $80.50 No ChangeN/A0 $0.81 12/15/2022100 shares $85.00 -50.0%N/A0 $0.85 11/30/2022200 shares $171.04 No ChangeN/A0 $0.86 11/15/2022200 shares $162.00 No ChangeN/A0.5 $0.81 10/31/2022200 shares $183.22 No ChangeN/A1 $0.92 10/15/2022200 shares $157.60 No ChangeN/A0.1 $0.79 9/30/2022200 shares $138.56 No ChangeN/A0.1 $0.69 9/15/2022200 shares $166.00 No ChangeN/A0.1 $0.83 8/31/2022200 shares $156.22 +100.0%N/A0 $0.78 8/15/2022100 shares $83.20 -66.7%N/A0 $0.83 7/31/2022300 shares $290.91 -57.1%N/A0 $0.97 7/15/2022700 shares $510.02 No ChangeN/A0.1 $0.73 6/30/2022700 shares $567.00 No ChangeN/A0.2 $0.81 6/15/2022700 shares $700.00 -53.3%N/A0.4 $1.00 5/31/20221,500 shares $1,365.00 +15.4%N/A0.7 $0.91 5/15/20221,300 shares $1,430.00 +62.5%N/A0.3 $1.10 4/30/2022800 shares $657.19 No ChangeN/A0.1 $0.82 4/15/2022800 shares $584.00 No ChangeN/A0.3 $0.73 3/31/2022800 shares $647.12 No ChangeN/A8 $0.81 3/15/2022800 shares $648.00 No ChangeN/A0.4 $0.81 2/28/2022800 shares $631.28 No ChangeN/A0.4 $0.79 2/15/2022800 shares $664.96 -11.1%N/A0.2 $0.83 1/31/2022900 shares $657.99 No ChangeN/A9 $0.73 1/15/2022900 shares $747.00 +28.6%N/A0.1 $0.83 12/31/2021700 shares $507.50 No ChangeN/A0.2 $0.73 12/15/2021700 shares $492.79 -12.5%N/A0.2 $0.70 11/30/2021800 shares $624.00 No ChangeN/A0.7 $0.78 11/15/2021800 shares $632.00 No ChangeN/A0.2 $0.79 10/29/2021800 shares $612.00 No ChangeN/A2.7 $0.77 10/15/2021800 shares $642.16 No ChangeN/A0.8 $0.80 9/30/2021800 shares $619.19 No ChangeN/A0.4 $0.77 9/15/2021800 shares $647.74 No ChangeN/A0.2 $0.81 8/31/2021800 shares $661.92 No ChangeN/A1.3 $0.83 8/13/2021800 shares $714.32 No ChangeN/A1.3 $0.89 7/30/2021800 shares $726.56 No ChangeN/A0.5 $0.91 7/15/2021800 shares $784.00 -27.3%N/A0.1 $0.98 6/30/20211,100 shares $1,027.74 +37.5%N/A2.8 $0.93 6/15/2021800 shares $727.28 -46.7%N/A0.3 $0.91 5/28/20211,500 shares $1,691.85 -16.7%N/A0.4 $1.13 5/14/20211,800 shares $1,998.00 +125.0%N/A0.1 $1.11 4/30/2021800 shares $1,056.00 No ChangeN/A0 $1.32 4/15/2021800 shares $1,056.00 No ChangeN/A0.2 $1.32 3/31/2021800 shares $888.00 -95.7%N/A0.1 $1.11 3/15/202118,800 shares $25,889.48 +129.3%N/A2.4 $1.38 2/26/20218,200 shares $10,414.00 +22.4%N/A0.8 $1.27 2/12/20216,700 shares $8,777.00 +97.1%N/A0.7 $1.31 1/29/20213,400 shares $3,978.00 -85.7%N/A0.1 $1.17 1/15/202125,400 shares $30,226.00 +70.5%N/A0.8 $1.19 12/31/202017,800 shares $16,958.06 -29.9%N/A0.4 $0.95Vladimir Lenin was right… (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. 12/15/202025,400 shares $16,637.00 +70.5%N/A0.8 $0.66 11/30/202014,900 shares $8,269.50 +84.0%N/A1.4 $0.56 11/15/20208,100 shares $4,880.25 +14.1%N/A3.5 $0.60 10/30/20207,100 shares $4,488.62 -17.4%N/A2.8 $0.63 10/15/20208,600 shares $6,268.54 +196.6%N/A1.4 $0.73 9/30/20202,900 shares $1,965.62 +262.5%N/A1.3 $0.68 9/15/2020800 shares $592.00 No ChangeN/A0.1 $0.74 8/31/2020800 shares $648.00 -86.0%N/A0.1 $0.81 8/14/20205,700 shares $4,758.93 -1.7%N/A4.8 $0.83 7/31/20205,800 shares $4,872.00 No ChangeN/A4.5 $0.84 7/15/20205,800 shares $4,698.00 +176.2%N/A1.8 $0.81 6/30/20202,100 shares $1,710.66 +90.9%N/A0.4 $0.81 6/15/20201,100 shares $770.00 No ChangeN/A2.8 $0.70 5/29/20201,100 shares $869.00 No ChangeN/A0.8 $0.79 5/15/20201,100 shares $825.00 No ChangeN/A0.7 $0.75 4/15/2020400 shares $680.00 +300.0%N/A0.8 $1.70 3/31/2020100 shares $124.00 -92.9%N/A0 $1.24 3/13/20201,400 shares $2,226.00 +1,300.0%N/A0.6 $1.59 2/28/2020100 shares $141.00 -50.0%N/A0 $1.41 2/14/2020200 shares $292.00 No ChangeN/A0.2 $1.46 1/31/2020200 shares $572.00 -50.0%N/A0.7 $2.86 1/15/2020400 shares $1,124.00 -79.0%N/A0.4 $2.81 MCUJF Short Interest - Frequently Asked Questions What is Medicure's current short interest? Short interest is the volume of Medicure shares that have been sold short but have not yet been covered or closed out. As of December 15th, investors have sold 900 shares of MCUJF short. Learn More on Medicure's current short interest. How does Medicure's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Medicure: Palatin Technologies, Inc. (5.30%), MIRA Pharmaceuticals, Inc. (5.87%), Exicure, Inc. (5.56%), Cocrystal Pharma, Inc. (0.25%), Hookipa Pharma Inc (0.42%), BioXcel Therapeutics, Inc. (2.12%), Pulmatrix, Inc. (2.05%), GeoVax Labs, Inc. (5.42%), Cara Therapeutics, Inc. (0.72%), Bolt Biotherapeutics, Inc. (0.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Medicure stock? Short selling MCUJF is an investing strategy that aims to generate trading profit from Medicure as its price is falling. MCUJF shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medicure? A short squeeze for Medicure occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MCUJF, which in turn drives the price of the stock up even further. How often is Medicure's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MCUJF, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies PTN Short Squeeze MIRA Short Squeeze XCUR Short Squeeze COCP Short Squeeze HOOK Short Squeeze BTAI Short Squeeze PULM Short Squeeze GOVX Short Squeeze CARA Short Squeeze BOLT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MCUJF) was last updated on 1/8/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredDonald Trump to Repeal Executive Order #14110?Nvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredBuy this Stock before Trump Takes Office!We're issuing an urgent "buy alert" on a little-known "AI company" set to SOAR under this new administration. ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicure Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.